Enhancement of noradrenergic neural transmission: An effective therapy of myasthenia gravis: A report on 52 consecutive patients

Journal of Medicine

Volumn 31, Issue 5-6, 2000, Pages 333-361

  Lechin, Fuad ^a,c   Van Der Dijs, Bertha ^a   Pardey Maldonado, Betty ^a   Jahn, Eduardo ^a   Jimenez, Vladimir ^a   Orozco, Beatriz ^a   Baez, Scarlet ^a   Lechin, Marcel E ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c NONE   (Venezuela)

Author keywords

Myasthenia gravis and Th2 immune disorders; Myasthenia gravis treatment; Noradrenergic neural transmission; Serotonin and autoimmune disorders; Sympathetic activity and autoimmune disorders

Indexed keywords

BUSPIRONE; SEROTONIN;

ADOLESCENT; ADRENERGIC TRANSMISSION; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROTRANSMISSION; ORAL GLUCOSE TOLERANCE TEST; SPINAL CORD MOTONEURON; SYMPATHETIC TONE; TH1 CELL; TH2 CELL; THROMBOCYTE AGGREGATION; THYMECTOMY;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; BENZHYDRYL COMPOUNDS; BUSPIRONE; DESIPRAMINE; DRUG THERAPY, COMBINATION; ELECTROMYOGRAPHY; EPINEPHRINE; FEMALE; HUMANS; HYDROXAMIC ACIDS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PHENYLALANINE; PLATELET AGGREGATION; PROPRANOLOL; SEROTONIN; SEROTONIN AGONISTS; SYMPATHETIC NERVOUS SYSTEM; TYROSINE;

EID: 0034447110     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Aarli, J.A. (1999).: Late-onset myasthenia gravis. A changing scene. Arch. Neurol. 56: 25-27.
2. Ackerman, K.D., Felten, S.Y., Bellinger, D.L., Livnat, S. and Felten, D.L. (1987).: Noradrenergic sympathetic innervation of spleen and lymph nodes in relation to specific cellular compartments. In: Progress in Immunology Edited by B. Cynader and R.G. Miller. Academic Press. Orlando, FL. 4: 588-600.
3. Anderson, A. and Harvey, A. (1988).: Effects of the facilitatory compounds cathecol, guanidine, noradrenaline, and phencyclidine on presynaptic currents of mouse motor nerve terminals. Naunyn-Schmiedeberg's Arch. Pharmacol. 338: 133-137.
4. Arnason, B.G.W. (1993).: The sympathetic nervous system and the immune response. In: Clinical autonomous disorders. Evaluation and management. Edited by P. Low. Little Brown, London, pp 143-165.
5. Arranz, B., Blennow, K., Ekman, R., Eriksson, A., Mansson, J-E. and Marcusson, J. (1996).: Brain monoaminergic and neuropeptidergic variations in human aging. J. Neural Transm. 103: 101-115.
6. Bamshad, M., Kay Song, C. and Bartnes, T.J. (1999).: CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 276(Regulatory Integrative Comp Physiol 45): R1569-R1578.
7. Barnard, A., Mahon, B.P., Watkins, J., Redhead, K. and Mills, K.H.G. (1996).: Th1/Th2 cell dichotomy in acquired immunity to Bordetella Pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87: 372-380.
8. Bencsics, A., Sershen, H., Baranyi, M., Hashim, A., Lajtha, H.A. and Vizi, E.S. (1997).: Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes. Brain Res. 761: 236-243.
9. Besedowsky, H.O., del Rey, A.E., Sorkin, E., Da Prada, M. and Keller, H.H. (1979).: Immunoregulation mediated by the sympathetic nervous system. Cell Immunol. 48: 346-355.
10. Binder, M.D. and Powers, R.K. (1999).: Synaptic integration in spinal motoneurons. J. Physiol. 93: 71-79.
11. Born, G.V.R. (1962).: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929.
12. Brustein, E. and Rossignol, S. (1999).: Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. II. Effects of noradrenergic and serotonergic drugs. J. Neurophysiol. 81: 1513-1530.
13. Bukcharaeva, E.A., Kim, K.C., Moravec, J., Nikolsky, E.E. and Vyskocil, F. (1999).: Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions. J. Physiol. 517: 879-888.
14. Carlson, S.L., Fox, S. and Abell, K.M. (1997).: Catecholamine modulation of lymphocyte homing to lymphoid tissues. Brain Behav. Immun. 11: 307-320.
15. Cook-Mills, J.M., Cohen, R.L., Pearlman, R.L. and Chambers, D.A. (1995).: Inhibition of lymphocytes activation by catecholamines: Evidence for a non-classical mechanism of catecholamine action. Immunology 5: 544-549.
16. Crary, B., Houser, S.L., Borysenko, M., Kutz, L., Hovan, C., Ault, K.A., Wayner, H.L. and Benson, H. (1983).: Decreased mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans. J. Immunol. 130: 694-697.
17. Cunnick, J.E., Lysle, D.T., Kucinski, B.J. and Rabin, B.S. (1990).: Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral beta-adrenergic receptors. Pharmacol. Biochem. Behav. 36: 645-651.
18. Daugaard, J.R., Laustsen, L., Hansen, B.S. and Richter, E.A. (1998).: Growth hormone induces muscle fiber type transformation in growth hormone-deficient rat. Acta Physiol. Scand. 164: 119-126.
19. Duteil, J., Rambert, F.A., Pessonnier, J., Gombert, R. and Assous E. (1990).: Central alpha 1-adrenergic stimulation in relation to the behavior stimulating effect of modafinil; studies with experimental animals. Eur. J. Pharmacol. 180: 49-58.
20. Elam, M., Thoren, P. and Svenson, T.H. (1986).: Locus coeruleus neurons and sympathetic nerves: Activation by visceral afferents. Brain Res. 375: 117-125.
21. Ernstrom, U. and Sandberg, G. (1973).: Effects of alpha- and beta-receptor stimulation on the release of lymphocytes and granulocytes from the spleen. Scand. J. Hematol. 11: 275-286.
22. Esler, M.D., Wallin, G., Dorward, P.K., Eisenhofer, G., Westerman, R., Meredith, I., Lambert, G., Cox, H.S. and Jennings, G. (1991).: Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Amer. J. Physiol. 260:R817-R823.
23. Faxvaag, A., Espevik, T. and Dalen, A. (1995).: An immunosuppressive murine leukaemia virus induces a Th-1 →Th-2 switch and abrogates the IgM antibody response to sheep erythrocytes by suppressing the production of IL-2. Clin. Exp. Immunol. 102: 487-495.
24. Felsner, P., Hofer, D., Rinner, I., Porta, S., Korsatko, W. and Schauenstein, K. (1995).: Adrenergic suppression of peripheral blood T cell reactivity in the rat is due to activation of peripheral alpha2-receptors. J. Neuroimmunol. 57: 27-34.
25. Felten, D.L., Felten, S.Y., Bellinger, D.L., Carlson, S.L., Ackerman, K.D., Madden, K.S., Olschowky, J.A. and Livnat, S. (1987).: Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol. Rev. 100: 225-260.
26. Felten, S.Y. and Olschowka, J.A. (1987).: Noradrenergic sympathetic innervation of the spleen. II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18: 37-48.
27. Fishman, R.H., Feigembaum, J.J., Yanai, J. and Klawans, H.L. (1983).: The relative importance of dopamine and norepinephrine in mediating locomotor activity. Prog. Neurobiol. 20: 55-88.
28. Fuchs, B.A., Campbell, K.S. and Munson, A.E. (1988).: Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol. 117: 339-351.
29. Gerin, C. and Privat, A. (1998).: Direct evidence for the link between monoaminergic descending pathways and motor activity: II. A study with microdialysis probes implanted in the ventral horn of the spinal cord. Brain Res. 794: 169-173.
30. Gerli, R., Paganelli, R., Cossarizza, A., Muscat, C., Piccolo, G., Barbieri, D., Mariotti, S., Monti, D., Bistoni, O., Raiola, E., Venanzi, F.M., Bertotto, A. and Franceschi, C. (1999).: Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J. Allergy Clin. Immunol. 103: 865-872.
31. Grassi, F. (1999).: 5-hydroxytryptamine blocks the fetal more potently than the adult mouse muscle acetylcholine-receptor. Pflügers Arch. - Eur. J. Physiol. 437: 903-909.
32. Jabre, J.F. and Salzsieder, B.T. (1999).: An EMG study of functional cortico-motoneuronal connections in humans. J. Physiol. 93: 147-154.
33. Jackson, J.C., Walker, R.F., Brooks, W.H. and Roszman, T.L. (1998).: Specific uptake of serotonin by murine macrophages. Life Sci. 42: 1641-1650.
34. Jaretzki III, A. (1997).: Thymectomy for myasthenia gravis: Analysis of the controversy regarding technique and results. Neurology 48(Suppl 5): S52-S63.
35. Kappel, M., Poulsen, T.D., Galbo, H. and Pedersen, D.K. (1998).: Effects of elevated plasma noradrenaline concentration on the immune system in humans. Eur. J. Appl. Physiol. 79: 93-98.
36. Kappel, M., Tvede, N., Galbo, H., Haahr, P.M., Kjaer, M., Klarlund, K. and Pedersen, B.K. (1991).: Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine. J. Appl. Physiol. 70: 2530-2534.
37. Karussis, D.M., Lehmann, D., Brenner, T., Wirguin, I., Mizrachi, K.R., Sicsic, C. and Abramsky, O. (1994).: Immunomodulation of experimental autoimmune myasthenia gravis with linomide. J. Neuroimmunol. 55: 187-193.
38. Kelley, K.W. (1989).: Growth hormone, lymphocytes and macrophages. Biochem. Pharmacol. 38: 705-713.
39. Kernell, D., Bakels, R. and Copray, J.C.V.M. (1999).: Discharge properties of motoneurones: How are they matched to the properties and use of their muscle units? J. Physiol. 93: 87-96.
40. Kouassi, E., Li, Y.S. and Revillard, J.P. (1990).: Catecholamine regulation of mouse B cell activation: functional dichotomy between lps and anti-immuno-globulin antibody responses. In: Messengers in a Neuroimmune Axis. Edited by M.S. O'Dorisio and A. Panerai. Ann. N.Y. Acad. Sci., New York, 594: 391-392.
41. Lake, C.R., Ziegler, M.G. and Kopin, I.J. (1976).: Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci. 18: 1315-1326.
42. Lambert, G.W., Kaye, D.M., Thompson, J.M., Turner, A.G., Cox, H.S., Vaz, M., Jennings, G.L., Wallin, B.G. and Esler, M.D. (1998).: Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta Physiol. Scand. 163: 155-163.
43. Larsson, P.T., Hjemdahl, P., Olsson, G., Egberg, N. and Hornstra, G. (1989).: Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry. Clin. Sci. 76: 369-376.
44. Lechin, F., van der Dijs, B. and Benaim, M. (1996a).:Stress vs depression. (Review). Prog. Neuro-Psychopharmacol. Biol. Psychiat. 20: 899-950.
45. Lechin, F., van der Dijs, B. and Lechin, M. (1996b).: Plasma neurotransmitters and functional illness. (Review) Psychother. Psychosom. 65:293-318.
46. Lechin, F., van der Dijs, B. and Lechin, E. (1979a).: The Autonomic Nervous System: Physiological basis of psychosomatic therapy. Barcelona, Spain: Editorial Cientifico-Medica, Chapter III, pp 31-40.
47. Lechin, F., van der Dijs, B. and Lechin, E. (1979b).: The Autonomic Nervous System: Physiological basis of psychosomatic therapy. Barcelona, Spain: Editorial Cientifico-Medica, Chapter VIII, pp 119-49.
48. Lechin, F., van der Dijs, B., Orozco, B., Lechin, M.E. and Lechin, A.E. (1996c).: Increased levels of free-serotonin in plasma of symptomatic asthmatic patients. Ann. Allergy Asthma Immunol. 77: 245-253.
49. Lechin, F., van der Dijs, B., Orozco, B., Baez, S., Rada, I., Garcia, Z., Jara, H., Lechin, A.E. and Lechin, M.E. (1996d).: Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise stress test in healthy humans before and after parasympathetic blockade with atropine. Res. Comm. Biol. Psychol. Psychiat. 21: 55-71.
50. Lechin, F., van der Dijs, B., Orozco, B., Lechin, A.E., Baez, S., Lechin, M.E., Benaim, M., Acosta, E., Arocha, L., Jimenez, V., Leon, G. and Garcia, Z. (1996e).: Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise in severely ill patients: a model of failing to cope with stress. Psychother. Psychosom. 65: 129-136.
51. Lechin, F., van der Dijs, B., Jara, H., Baez, S., Orozco, B., Jahn, E., Lechin, M.E., Jimenez, V. and Lechin, A.E. (1997a).: Successful neuropharmacological treatment of myasthenia gravis: Report of eight cases. Res. Comm. Biol. Psychol. Psychiat. 22: 83-96.
52. Lechin, F., van der Dijs, B., Jara, H., Orozco, B., Baez, S., Jahn, E., Benaim, M., Lechin, E., Lechin, M.E., Jimenez, V. and Lechin, A.E. (1997b).: Plasma neurotransmitter profiles of anxiety, phobia and panic disorder patients. Acute and chronic effects of buspirone. Res. Comm. Biol. Psychol. Psychiat. 22:113-156.
53. Lechin, F., van der Dijs, B., Lechin, M.E., Orozco, B., Baez, S., Lechin, A.E., Jahn, E. and Jimenez V. (1997c).: Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis, and moderate exercise conditions in two types of hypertensive patients. Res. Comm. Biol. Psychol. Psychiat 22: 97-112.
54. Lechin, F., van der Dijs, B., Jara, H., Orozco, B., Báez, S., Benaim, M., Lechin, M. and Lechin, A. (1998a).: Effects of buspirone on plasma neurotransmitters in healthy subjects. J. Neural Transmission 105: 561-573.
55. Lechin, F., van der Dijs, B., Orozco, B., Jara, H., Rada, I., Lechin, M.E. and Lechin, A.E. (1998b).: Neuropharmacological treatment of bronchial asthma with an antidepressant drug: tianeptine. A double-blind crossover placebo-controlled study. Clin. Pharmacol. Ther. 64: 223-232.
56. Lechin, F., van der Dijs, B., Orozco, B., Jara, H., Rada, I., Lechin, M.E. and Lechin, A.E. (1998c).: The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: A double-blind, crossover, placebo-controlled study. J. Clin. Pharmacol. 38:918-925.
57. Lechin, F., van der Dijs, B., Orozco, B., Lechin, M.E., Baez, S., Lechin, A.E., Rada, I., Acosta, E., Arocha, L., Jimenez, V., Leon, G. and Garcia, Z. (1995a).: Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol. Psychiatry 38: 166-173.
58. Lechin, F., van der Dijs, B., Orozco, B., Lechin, A.E., Baez. S., Lechin, M.E., Rada, I., Acosta, E., Arocha, L., Jimenez, V., Leon, G. and Garcia, Z. (1995b).: Plasma neurotransmitters, blood pressure, and heart rate during supine resting, othostasis, and moderate exercise in dysthymic depressed patients. Biol. Psychiatry 37: 884-891.
59. Lechin, F., van der Dijs, B., Vitelli-Flores, G., Baez, S., Lechin, M.E., Lechin, A.E., Orozco, B., Rada, I., Leon, G. and Jimenez, V. (1994).: Peripheral blood immunological parameters in long-term benzodiazepine users. Clin. Neuropharmacol. 17: 63-72.
60. Lechin, F., van der Dijs, B., Lechin, M.E., Jara, H., Lechin, A., Baez, S., Orozco, B., Rada, I., Cabrera, A., Arocha, L., Jimenez, V. and Leon, G. (1993).: Plasma neurotransmitters throughout oral glucose tolerance test in non-depressed essential hypertension patients. Clin. Exper. Hypertension 15: 209-240.
61. Lechin, F., van der Dijs, B., Lechin, M.E., Baez, S., Jara, H., Lechin, A., Orozco, B., Rada, I., Cabrera, A., Jimenez, V. and Leon, G. (1992).: Effects of an oral glucose load on plasma neurotransmitters in humans: involvement of REM sleep? Neuropsychobiology 26: 4-11.
62. Lechin, F., van der Dijs, B., Lechin, A.E., Lechin, M.E., Coll-Garcia, E., Jara, H., Cabrera, A., Jimenez, V., Gomez, F., Tovar, D., Rada, I. and Arocha, L. (1991).: Doxepin therapy for postprandial symptomatic hypoglycemic patients: neurochemical, hormonal and metabolic disturbances. Clin. Sci. 80: 373-384.
63. Lechin, F., van der Dijs, B., Vitelli-Florez, G., Lechin-Báez, S., Azocar, J., Cabrera, A., Lechin, A., Jara, H., Lechin, M., Gómez, F. and Arocha, L. (1990a).: Psychoneuroendocrinological and immunological parameters in cancer patients: involvement of stress and depression. Psychoneuroendocrinology 15: 425-451.
64. Lechin, F., van der Dijs, B., Rada, I., Jara, H., Lechin, A.E., Cabrera, A., Lechin, M.E., Jimenez, V., Gómez, F., Villa, S., Acosta, E. and Arocha L. (1990b).: Plasma neurotransmitters and cortisol in duodenal ulcer patients: role of stress. Dig. Dis. Sci, 35: 1313-1319.
65. Lechin, F., van der Dijs, B., Lechin, M., Camero, R., Lechin, A., Villa, S. and Reinfeld, B. (1989).: Intramuscular clonidine test in severely diseased patients. In: Neurochemistry and Clinical Disorders: Circuitry of Some Psychiatric and Psychosomatic Syndromes. Edited by F. Lechin and B. van der Dijs. CRC Press, Boca Raton, FL. pp 215-226.
66. Lechin, F., van der Dijs, B., Jackubowicz, D., Camero, R.E., Villa, S., Arocha, L. and Lechin, A.E. (1985a).: Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone depressed patients. Neuroendocrinology 41: 156-162.
67. Lechin, F., van der Dijs, B., Jackubowicz, D., Camero, R.E., Villa, S., Lechin, E. and Gomez, F. (1985b).: Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone subjects. Neuroendocrinology 40: 253-261.
68. Livnat, S., Felten, S.Y., Carlson, S.L., Bellinger, D.L. and Felten, D.L. (1985).: Involvement of peripheral and central catecholamine systems in neural-immune interactions. J. Neuroimmunol. 10: 5-30.
69. Lorton, D., Hewitt, D., Bellinger, D.L., Felten, S.Y. and Felten, D.L. (1990).: Noradrenergic reinnervation of the rat spleen following chemical sympathectomy with 6-hydroxydopamine: Pattern and time course of reinnervation. Brain Behav. Immun. 4: 198-222.
70. Madden, K.S., Felten, S.Y., Felten, D.L., Hardy, C.A. and Livnat, S. (1994a).: Sympathetic nervous system modulation of the immune system. II. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J. Neuroimmunol. 49: 67-75.
71. Madden, K.S., Moynihan, J.A., Brenner, G.J., Felten, S.Y., Felten, D.L. and Livnat, S. (1994b).: Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. NeuroimmunoL 49: 77-87.
72. Mantegazza, R., Antozzi, C., Peluchetti, D., Sghirlanzoni, A. and Cornelio, F. (1988).: Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J. Neurol. 235:449-453.
73. Mendell, J.R. and Florence, J. (1990).: Manual muscle testing. Muscle Nerve 13:516-520.
74. Mokhtarian, F., Shirazian, D. and Grob, D. (1993).: Production of interferon gamma and interleukin-2 by peripheral blood lymphocytes of patients with Myasthenia gravis and other autoimmune diseases. In: Myasthenia Gravis and Related Disorders: Experimental and Clinical Aspects. Edited by S. Penn, D.P. Richman, R.L. Ruff, and V.A. Lennon. Ann. N.Y. Acad. Sci., New York. 681:315-318.
75. Musgrave, I.F., Bachmann, A.W., Jackson, R.V. and Gordon, R.D. (1985).: Increased plasma noradrenaline during low dose adrenaline infusion in resting man and during sympathetic stimulation. Clin. Exp. Pharmacol. Physiol. 12: 285-289.
76. Musso, N.R., Brenci, S., Indiveri, F. and Lotti, G. (1997).: L-tyrosine and nicotine induce synthesis of L-Dopa and norepinephrine in human lymphocytes. J. Neuroimmunol. 74: 117-120.
77. Nicholson, L.B. and Kuchroo, V. (1996).: Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8: 837-842.
78. Osserman, K.E. and Genkins, G. (1966).: Critical reappraisal of the use of edrophonium (tensilon) chloride test in myasthenia gravis and significance of clinical classification. N.Y.: Ann. N.Y. Acad. Sci. 135:312-334.
79. Paegelow, I., Werner, H., Hagen, M., Wartner, U. and Lange, P. (1985).: Influence of serotonin on lymphokine secretion in vitro. Int. J. Immunopharmacol. 7: 889-896.
80. Piercey, M.F., Smith, M.W. and Lum-Ragan, J.T. (1994).: Excitation of noradrenergic cell firing by 5-hydroxytryptamine 1A agonists correlates with dopamine antagonist properties. J. Pharmacol. Exp. Ther. 268: 1297-1303.
81. Ragheb, S. and Lisak, R.P. (1993).: Phenotypic and functional abnormalities of B cells in myasthenia gravis. In: Miasthenia Gravis and Related Disorders: Experimental and Clinical Aspects. Edited by S. Penn, D.P. Richman, R.L. Ruff, and V.A. Lennon. Ann. N.Y. Acad. Sci., New York. 681: 257-262.
82. Rodriguez-Manso, G. (1999).: Yohimbine interacts with the dopaminergic system to reverse sexual satiation: further evidence for a role of sexual motivation in sexual exhaustion. Eur. J. Pharmacol. 372: 1-8.
83. Romagnani, S. (1996).: TH1 and TH2 in human diseases. Clin. Immunol. Immunopathol. 80: 225-235.
84. Ross, S.E., Williams, R.O., Mason, L.J., Mauri, C., Marinova-Mutafchieva, L., Malfait, A.M., Maini, R.N. and Feldmann, M. (1987).: Suppression of TNFalpha expression, inhibition of th1 activity, and amelioration of collagen-induced arthritis by Rolipram. J. Immunol. 159: 6253-6259.
85. Roszman, T.L. and Carlson, S.L. (1991).: Neurotransmitters and molecular signalling in the immune response. In: Psychoneuroimmunology. Edited by R. Ader, D.L. Felten and N. Cohen. Academic Press, San Diego, pp. 311-339.
86. Schedlowski, M., Hosch, W., Oberbeck, R., Benschop, R.J., Jacobs, R., Raab, H.R. and Smidt, R.E. (1996).: Catecholamines modulate human NK cell circulation and function via spleen-independent beta2-adrenergic mechanisms. J. Immunol. 156: 93-99.
87. Sokoloff, A.J., Siegel, S.G. and Kope, T.C. (1999).: Recruitment order among motoneurons from different motor nuclei. J. Neurophysiol. 81: 2485-2492.
88. Spengler, R.N., Allen, R.M., Remick, D.G., Strieter, R.M. and Kunkel, S.L. (1990).: Stimulation of alpha adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145: 1430-1434.
89. Sternberg, E.M., Wedner, H.J., Leung, M.K. and Parker, C.W. (1987).: Effect of serotonin (5-HT) and other monoamine on murine macrophages: modulation of interferon-gamma induced phagocytosis. J. Immunol. 138(12): 4360-4365.
90. Sugrue, M.F. (1983).: Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol. Then 21: 1-33.
91. Talal, N., Dauphinee, M. and Ahmed, S.A. (1998).: CD5 B cells in autoimmunity. In: CD5 B Cells in Development and Disease. Edited by L.A. Herzenberg, G. Haughton and K. Rajewsky. Ann. N.Y. Acad. Sci., New York. 651: 551-562.
92. Tang, Y., Shankar, R., Gamelli, R. and Jones, S. (1999).: Dynamic norepinephrine alterations in bone marrow: Evidence of functional innervation. J. Neuroimmunol. 96: 182-189.
93. Thompson, J.M., Wallin, B.G., Lambert, G.W., Jennings, G.L. and Esler, M.D. (1998).: Human muscle sympathetic activity and cardiac catecholamine spillover: No support for augmented sympathetic noradrenaline release by adrenaline co-transmission. Clin. Sci. 94: 383-393.
94. Thyaga-Rajan, S., Madden, K.S., Stevens, S.Y. and Felten, D.L. (1999).: Effects of 1-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats. J. Neuroimmunol. 96: 57-65.
95. Tiedt, T.N., Albuquerque, E.X., Hudson, S.C. and Rash, J.E. (1978).: Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology. J. Pharmacol. Exp. Ther. 205: 326-339.
96. Tvede, N., Kappel, M., Klarlund, K., Duhn, S., Halkjaer-Kristensen, J., Kjaer, M., Galbo, H. and Pedersen, B.K. (1994).: Evidence that the effect of bicycle exercise on blood mononuclear cell proliferative responses and subsets is mediated by epinephrine. Int. J. Sports Med. 15: 100-104.
97. 2-adrenergic, spleen dependent process. Am. J. Physiol. 258: E191-E202.
98. 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension. Fundam. Clin. Pharmacol. 11: 567-575.
99. Vredevoe, D.L., Moser, D.K., Gan, X.H. and Bonavida, B. (1995).: Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine. Neuroimmunomodulation 2: 16-24.
100. Wada, T., Hasegawa, Y. and Ono, H. (1997).: Characterization of alpha-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity. Eur. J. Pharmacol. 340: 45-52.
101. Walker, R.F. and Codd, E.E. (1985).: Neuroimmunomodulatory interaction of norepinephrine and serotonin. J. Neuroimmunol. 10:41-58.
102. Warren, R.P., Kane, K.K., Burger, R.A. and Singh, V.K. (1990).: Serotonin induced suppression of lymphocyte DNA synthesis and natural killer eel! activity. In: Neuropeptides and Immunopeptides: Messengers in a Neuroimmune Axis. Edited by M.S. O'Dorisio and A. Panerai. Ann. N.Y. Acad. Sci., New York. 594: 429-431.
103. Wessler, I. (1992).: Acetylcholine and motor nerves: storage, release, and presynpatic modulation by autoreceptors and adrenoceptors. Int. Rev. Neurobiol. 34: 283-373.
104. Yan, Q-S., Jobe, P.C. and Dailey, J.W. (1993).: Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: Studies with microdialysis. Brain Res. 610: 24-31.
105. Yi, Q. and Lefvert, K. (1993).: Human muscle acetylcholine receptor reactive T and B lymphocytes in myasthenia gravis. In: Myasthenia Gravis and Related Disorders: Experimental and Clinical Aspects. Edited by S. Penn, D.P. Richman, R.L. Ruff and V.A. Lennon. Ann. N.Y. Acad. Sci., New York. 681: 339-341.
106. Young, M.R.I. and Matthews, J.P. (1995).: Serotonin regulation of T cell subpopulations and of macrophage accessory function. Immunology 84: 148-152.
107. Zhang, G-X., Yu, L-Y., Shi, F-D., Xiao, B-G., Björk, J., Hedlund, G. and Link, H. (1997).: Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 73: 175-182.
108. Ziegler, M.G., Lake, C.R. and Wood, J.H. (1977).: Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for norepinephrine. J. Neurochem. 28: 677-679.